SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-194806
Filing Date
2014-05-12
Accepted
2014-05-12 16:07:56
Documents
13
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d705977d10q.htm 10-Q 484015
2 EX-10.1 d705977dex101.htm EX-10.1 394684
3 EX-31.1 d705977dex311.htm EX-31.1 5505
4 EX-31.2 d705977dex312.htm EX-31.2 5504
5 EX-32.1 d705977dex321.htm EX-32.1 2970
6 EX-32.2 d705977dex322.htm EX-32.2 3000
13 GRAPHIC g705977ex10_1pg066.jpg GRAPHIC 12521
  Complete submission text file 0001193125-14-194806.txt   3240729

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT fprx-20140331.xml EX-101.INS 360050
8 XBRL TAXONOMY EXTENSION SCHEMA fprx-20140331.xsd EX-101.SCH 32778
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fprx-20140331_cal.xml EX-101.CAL 43459
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fprx-20140331_def.xml EX-101.DEF 81592
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE fprx-20140331_lab.xml EX-101.LAB 241725
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fprx-20140331_pre.xml EX-101.PRE 162859
Mailing Address TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080
Business Address TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS INC (Filer) CIK: 0001175505 (see all company filings)

IRS No.: 260038620 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36070 | Film No.: 14833483
SIC: 2834 Pharmaceutical Preparations